Aging Associated Transcriptomic Signatures in Tumor and Tumor Adjacent Lung Tissues Associated with Recurrence Following Resection of Stage I Lung Adenocarcinoma.
[BACKGROUND] Age is an independent prognostic factor in early-stage non-small cell lung cancer (NSCLC), yet the molecular differences between old and young patients and their contribution to disease p
- 표본수 (n) 256
APA
Darawshy F, Bayrak CS, et al. (2026). Aging Associated Transcriptomic Signatures in Tumor and Tumor Adjacent Lung Tissues Associated with Recurrence Following Resection of Stage I Lung Adenocarcinoma.. Research square. https://doi.org/10.21203/rs.3.rs-8971302/v1
MLA
Darawshy F, et al.. "Aging Associated Transcriptomic Signatures in Tumor and Tumor Adjacent Lung Tissues Associated with Recurrence Following Resection of Stage I Lung Adenocarcinoma.." Research square, 2026.
PMID
41836506
Abstract
[BACKGROUND] Age is an independent prognostic factor in early-stage non-small cell lung cancer (NSCLC), yet the molecular differences between old and young patients and their contribution to disease progression remain unclear. We investigated age-related transcriptomic differences in early-stage lung adenocarcinoma (LUAD) and their association with recurrence.
[METHODS] Tumor and adjacent normal lung tissue (NAT) from 126 stage I LUAD patients underwent bulk RNA sequencing to characterize age-related transcriptomic profiles. Differential expression and multiscale embedded gene co-expression network analysis (MEGENA) were used to identify age- and recurrence-associated modules. Pathways were annotated using Ingenuity Pathway Analysis. External confirmation was performed using TCGA (n=256) and TRACERx (n=83) cohorts.
[RESULTS] Based on the cohort's median age, 60 patients were classified as old (>70 years) and 66 as young (≤70 years). In tumors, older patients with recurrence showed marked upregulation of cancer-associated, inflammatory, and extracellular matrix pathways compared with older patients without recurrence. In NAT samples, older patients with recurrence demonstrated upregulation of inflammatory and cancer-associated pathways-including phagosome formation, IL-17, IL-6, and Th2 signaling-that were absent or downregulated in young patients. MEGENA revealed a larger number of recurrence-associated co-expression modules in old versus young patients. These age-related patterns were highly conserved in both external cohorts across tumor and NAT samples.
[CONCLUSION] Aging in LUAD is associated with distinct cancer- and inflammation-related transcriptomic alterations that contribute to recurrence. Aging-related molecular signatures may improve risk stratification for early-stage lung cancer.
[IMPACT] Aging shapes tumor microenvironment transcriptomes in stage I LUAD, enabling improved relapse risk stratification after surgery.
[METHODS] Tumor and adjacent normal lung tissue (NAT) from 126 stage I LUAD patients underwent bulk RNA sequencing to characterize age-related transcriptomic profiles. Differential expression and multiscale embedded gene co-expression network analysis (MEGENA) were used to identify age- and recurrence-associated modules. Pathways were annotated using Ingenuity Pathway Analysis. External confirmation was performed using TCGA (n=256) and TRACERx (n=83) cohorts.
[RESULTS] Based on the cohort's median age, 60 patients were classified as old (>70 years) and 66 as young (≤70 years). In tumors, older patients with recurrence showed marked upregulation of cancer-associated, inflammatory, and extracellular matrix pathways compared with older patients without recurrence. In NAT samples, older patients with recurrence demonstrated upregulation of inflammatory and cancer-associated pathways-including phagosome formation, IL-17, IL-6, and Th2 signaling-that were absent or downregulated in young patients. MEGENA revealed a larger number of recurrence-associated co-expression modules in old versus young patients. These age-related patterns were highly conserved in both external cohorts across tumor and NAT samples.
[CONCLUSION] Aging in LUAD is associated with distinct cancer- and inflammation-related transcriptomic alterations that contribute to recurrence. Aging-related molecular signatures may improve risk stratification for early-stage lung cancer.
[IMPACT] Aging shapes tumor microenvironment transcriptomes in stage I LUAD, enabling improved relapse risk stratification after surgery.